These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25860248)

  • 1. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.
    Oh YJ; An JN; Kim CT; Yang SH; Lee H; Kim DK; Joo KW; Paik JH; Kang SW; Park JT; Lim CS; Kim YS; Lee JP
    PLoS One; 2015; 10(7):e0132826. PubMed ID: 26177311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.
    Murakoshi M; Gohda T; Sonoda Y; Suzuki H; Tomino Y; Horikoshi S; Suzuki Y
    Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
    Gohda T; Kamei N; Kubota M; Tanaka K; Yamashita Y; Sakuma H; Kishida C; Adachi E; Koshida T; Murakoshi M; Hagiwara S; Funabiki K; Ueda S; Suzuki Y
    J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R
    BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N-acetyl-beta-D-glucosaminidase.
    Machiguchi T; Yoshida H; Yonemoto S; Minakata T; Nomura K; Muso E; Tamura T; Sasayama S
    Nephrol Dial Transplant; 1999 Mar; 14(3):635-40. PubMed ID: 10193812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 and their potential as markers of immunoglobulin A nephropathy activity.
    Miedziaszczyk M; Oko A; Wolc A; Woźniak A; Idasiak-Piechocka I
    Adv Clin Exp Med; 2024 Jun; 33(6):583-591. PubMed ID: 37962255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy.
    Chen J; Hu W; Xiao F; Lin L; Chen K; Wang L; Wang X; He Y
    Kidney Blood Press Res; 2019; 44(5):1063-1074. PubMed ID: 31487717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 renal expression as a biomarker for progressive IgAN.
    Sun S; Zhao A; Li R; Du R; He L; Sun W; Wang H; Huang C
    J Nephrol; 2015 Jun; 28(3):307-14. PubMed ID: 25510296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal expression of intercellular adhesion molecule-1 in immunoglobulin A nephropathy: tubulointerstitial injury and prognosis.
    Arrizabalaga P; Solé M; Abellana R; Ascaso C; Cardesa A
    Virchows Arch; 2001 Jul; 439(1):27-34. PubMed ID: 11499837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tubulointerstitial plasmin in the progression of IgA nephropathy.
    Uchida T; Oda T; Takechi H; Matsubara H; Watanabe A; Yamamoto K; Oshima N; Sakurai Y; Kono T; Shimazaki H; Tamai S; Kumagai H
    J Nephrol; 2016 Feb; 29(1):53-62. PubMed ID: 25971850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients.
    Hu Y; Shang M; Shi Y; Tao M; Yuan W; Tang L; Ma X; Cui B; Chen H; Zhou X; Zhuang S; Liu N
    Ren Fail; 2021 Dec; 43(1):684-697. PubMed ID: 33896334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
    Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy.
    Arrizabalaga P; Solé M; Abellana R; de las Cuevas X; Soler J; Pascual J; Ascaso C
    Am J Nephrol; 2003; 23(3):121-8. PubMed ID: 12566693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC; Zhang JJ; Chen M; Lv JC; Liu G; Zou WZ; Zhang H; Zhao MH
    Nephrol Dial Transplant; 2011 Oct; 26(10):3229-36. PubMed ID: 21402675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy.
    Tanaka K; Sugiyama H; Yamanari T; Mise K; Morinaga H; Kitagawa M; Onishi A; Ogawa-Akiyama A; Tanabe K; Eguchi J; Ohmoto Y; Shikata K; Wada J
    Nephrology (Carlton); 2018 Sep; 23(9):855-862. PubMed ID: 29987860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.